It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 | Hyderabad, Telangana, India | Struck OffTaksh Pharmaceuticals Private Limited, a struck off private limited company, was established on 27 April 2020 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74900TG2020PTC140199. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Gururaj Kulkarni (Director), Lalitha Kumari Pendyala (Director), Denkanikota Sunitha (Director). Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Flat No.317, Newmark Prithvi Homes, S.Y.No.121 & 122, Kompally, Hyderabad, Telangana, 500014.
U74900TG2020PTC140199
140199
27 April 2020
₹1.50 M
₹0.10 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Taksh Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gururaj Kulkarni | Director | 27 Apr 2020 | Current |
| Lalitha Kumari Pendyala | Director | 27 Apr 2020 | Current |
| Denkanikota Sunitha | Director | 27 Apr 2020 | Current |
| Pavithra Chandrashekar | Director | 27 Apr 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Taksh Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Taksh Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Taksh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Taksh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Taksh Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Taksh Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
The activity Taksh Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was completed.
The activity Gururaj Kulkarni was appointed as a Director was appointed as a Director on 27 Apr 2020 & has been associated with this company since 5 years 7 months . was completed.
Lalitha Kumari Pendyala was appointed as a Director was appointed as a Director on 27 Apr 2020 & has been associated with this company since 5 years 7 months . was recorded as a recent event.
Progress on Denkanikota Sunitha was appointed as a Director was appointed as a Director on 27 Apr 2020 & has been associated with this company since 5 years 7 months . was documented.
Progress on Pavithra Chandrashekar was appointed as a Director was appointed as a Director on 27 Apr 2020 & has been associated with this company since 5 years 7 months . was documented.
The CIN of Taksh Pharmaceuticals Private Limited is U74900TG2020PTC140199.
Taksh Pharmaceuticals Private Limited is headquartered at Flat No.317, Newmark Prithvi Homes, S.Y.No.121 & 122, Kompally, Hyderabad, Telangana, 500014.
Taksh Pharmaceuticals Private Limited was incorporated on 27 April 2020.
The current directors of Taksh Pharmaceuticals Private Limited are
The primary industry of Taksh Pharmaceuticals Private Limited is Pharma.
Taksh Pharmaceuticals Private Limited is unlisted.
The authorized capital of Taksh Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX